PRECURSOR FREQUENCY-ANALYSIS OF BRYOSTATIN ACTIVATED LYMPHOCYTES

被引:1
作者
FLEMING, MD
BARRETT, SK
BEAR, HD
机构
[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,DIV SURG ONCOL,RICHMOND,VA 23298
[2] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,MASSEY CANC CTR,RICHMOND,VA 23298
关键词
D O I
10.1006/jsre.1994.1113
中图分类号
R61 [外科手术学];
学科分类号
摘要
Bryostatin 1 (Bryo) is a potent activator of protein kinase C. When T cells are stimulated with Bryo and the calcium ionophore ionomycin (Io), they expand rapidly in low-dose IL-2 (20 U/ml). We have shown that Bryo/Io-activated T-cells from murine tumor-draining lymph nodes have striking antigen-specific antitumor efficacy in vivo. To account for the specificity despite using a nonspecific T cell activation method, it was postulated that the Bryo/Io combination might preferentially activate antigen-sensitized T cells. To test this hypothesis, an allogeneic response model was used. C57BL/6 mice were primed by intraperitoneal tip) injection with DBA/2 mouse splenocytes. After 9 days, the C57BL/6 spleens were harvested and H-2(d)-specific cytolytic T lymphocyte (CTL) precursor frequency (PF) was determined by limiting dilution analysis (LDA). A portion of the same spleen cells was treated for 18 hr with Bryo/Io and expanded for 7 days in IL-2 (20 U/ml); the LDA was then repeated to analyze PF after expansion. The entire experiment was also done with responder and stimulator strains reversed (DBA/ 2 mice immunized with C57BL/6 cells). The resulting PF values were [GRAPHICS] Normal spleen cells treated with Bryo/Io exhibited (10% release vs the same targets at any effector:target ratio, ruling out nonspecific cytolysis after Bryo/Io. T lymphocytes or CD8(+) T cells were selected from primed splenocytes and the PF values before and after Bryo/Io were analyzed. These data showed that the increase in PF after expansion could not be attributed to T cell or CD8(+) cell enrichment alone. Therefore, Bryo/Io treatment of lymphocytes from antigen sensitized mice apparently causes preferential activation and expansion of sensitized or memory T cells. (C) 1994 Academic Press, Inc.
引用
收藏
页码:74 / 79
页数:6
相关论文
共 23 条
[1]  
BEAR HD, 1988, CANCER RES, V48, P1422
[2]  
BYRNE JA, 1988, J IMMUNOL, V141, P3249
[3]  
CHANG AE, 1993, CANCER RES, V53, P1043
[4]  
CHOU T, 1988, J IMMUNOL, V141, P1775
[5]   MODULATION OF INVITRO AUTOLOGOUS MELANOMA-SPECIFIC CYTOTOXIC T-CELL RESPONSES BY PHORBOL DIBUTYRATE AND IONOMYCIN [J].
DARROW, TL ;
QUINNALLEN, MA ;
CROWLEY, NJ ;
SEIGLER, HF .
CELLULAR IMMUNOLOGY, 1990, 125 (02) :508-517
[6]  
HESS AD, 1988, J IMMUNOL, V141, P3263
[7]   ACTIVATION AND INVITRO EXPANSION OF TUMOR-REACTIVE LYMPHOCYTES-T FROM LYMPH-NODES DRAINING HUMAN PRIMARY BREAST CANCERS [J].
HOOVER, SK ;
FRANK, JL ;
MCCRADY, C ;
MCKINNON, JG ;
BEAR, HD .
JOURNAL OF SURGICAL ONCOLOGY, 1991, 46 (02) :117-124
[8]   AUTOLOGOUS TUMOR-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T IN THE INFILTRATE OF HUMAN METASTATIC MELANOMAS - ACTIVATION BY INTERLEUKIN-2 AND AUTOLOGOUS TUMOR-CELLS, AND INVOLVEMENT OF THE T-CELL RECEPTOR [J].
ITOH, K ;
PLATSOUCAS, CD ;
BALCH, CM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (04) :1419-1441
[9]  
ITOH K, 1986, CANCER RES, V46, P3011
[10]  
LIND DS, 1993, SURG ONCOL, V2, P273